Sangamo Therapeutics
SGMO
#10571
Rank
ยฃ23.28 M
Marketcap
ยฃ0.05620
Share price
0.00%
Change (1 day)
-81.97%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2026 (TTM): -ยฃ82.12 Million

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are ยฃ34.55 Million. In 2025 the company made an earning of -ยฃ82.03 Million a decrease over its 2024 earnings that were of -ยฃ74.77 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ82.12 Million0.11%
2025 -ยฃ82.03 Million9.71%
2024 -ยฃ74.77 Million-17.27%
2023 -ยฃ90.38 Million-40.88%
2022 -ยฃ0.16 Billion9.79%
2021 -ยฃ0.14 Billion41.52%
2020 -ยฃ98.4 Million23.17%
2019 -ยฃ79.89 Million36.33%
2018 -ยฃ58.6 Million36.89%
2017 -ยฃ42.81 Million-22.32%
2016 -ยฃ55.11 Million54.86%
2015 -ยฃ35.59 Million75.62%
2014 -ยฃ20.27 Million0.13%
2013 -ยฃ20.24 Million
2011 -ยฃ27.21 Million43.66%
2010 -ยฃ18.94 Million28.52%
2009 -ยฃ14.74 Million-23.55%
2008 -ยฃ19.28 Million2.45%
2007 -ยฃ18.82 Million19.5%
2006 -ยฃ15.75 Million50.78%
2005 -ยฃ10.45 Million75%
2004 -ยฃ5.97 Million-33.25%
2003 -ยฃ8.94 Million-62.27%
2002 -ยฃ23.7 Million102.82%
2001 -ยฃ11.69 Million23.21%
2000 -ยฃ9.49 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ14.21 B-17,069.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ8.39 B-10,117.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ0.33 B-503.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-ยฃ0.33 Billion 285.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-ยฃ1.93 Billion 2,196.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ5.10 B-6,193.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ0.92 B-1,207.17%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ33.16 M-139.58%๐Ÿ‡บ๐Ÿ‡ธ USA